MXPA02012089A - Metodo de tratamiento de la enfermedad de alzheimer con una proteina extraible de organos mamiferos. - Google Patents

Metodo de tratamiento de la enfermedad de alzheimer con una proteina extraible de organos mamiferos.

Info

Publication number
MXPA02012089A
MXPA02012089A MXPA02012089A MXPA02012089A MXPA02012089A MX PA02012089 A MXPA02012089 A MX PA02012089A MX PA02012089 A MXPA02012089 A MX PA02012089A MX PA02012089 A MXPA02012089 A MX PA02012089A MX PA02012089 A MXPA02012089 A MX PA02012089A
Authority
MX
Mexico
Prior art keywords
alzheimer
disease
treatment
mammalian organs
protein extractable
Prior art date
Application number
MXPA02012089A
Other languages
English (en)
Inventor
Alberto Panerai
Original Assignee
Rakepoll Holding B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rakepoll Holding B V filed Critical Rakepoll Holding B V
Publication of MXPA02012089A publication Critical patent/MXPA02012089A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

La invencion se refiere a un metodo de tratamiento de pacientes sufriendo de la enfermedad de Alzheimer que comprende la administracion de una cantidad eficaz de una proteina 14 kDa extraible de organos mamiferos, particularmente del higado mamifero.
MXPA02012089A 2000-06-08 2001-06-04 Metodo de tratamiento de la enfermedad de alzheimer con una proteina extraible de organos mamiferos. MXPA02012089A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20999800P 2000-06-08 2000-06-08
PCT/EP2001/006339 WO2001093896A2 (en) 2000-06-08 2001-06-04 A method of treatment of alzheimer's disease with a protein extractable from mammalian organs

Publications (1)

Publication Number Publication Date
MXPA02012089A true MXPA02012089A (es) 2004-08-19

Family

ID=22781198

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012089A MXPA02012089A (es) 2000-06-08 2001-06-04 Metodo de tratamiento de la enfermedad de alzheimer con una proteina extraible de organos mamiferos.

Country Status (7)

Country Link
US (1) US20030165492A1 (es)
EP (1) EP1286688A2 (es)
JP (1) JP2003535143A (es)
AU (1) AU2001279643A1 (es)
CA (1) CA2411432A1 (es)
MX (1) MXPA02012089A (es)
WO (1) WO2001093896A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9005154B2 (en) 2008-09-26 2015-04-14 Covidien Lp Valved hemodialysis catheter
US10143822B2 (en) 2012-07-05 2018-12-04 Covidien Lp Valved tip catheters
CU24626B1 (es) * 2019-12-26 2022-11-07 Centro Nac De Biopreparados Composición farmacéutica a base de proteínas con actividad neuroprotectora, inmunomoduladora, antiinflamatoria y antimicrobiana

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
US6277969B1 (en) * 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US6660268B1 (en) * 1994-03-18 2003-12-09 The President And Fellows Of Harvard College Proteasome regulation of NF-KB activity
IT1290828B1 (it) * 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche

Also Published As

Publication number Publication date
WO2001093896A3 (en) 2002-10-31
JP2003535143A (ja) 2003-11-25
AU2001279643A1 (en) 2001-12-17
WO2001093896A2 (en) 2001-12-13
US20030165492A1 (en) 2003-09-04
EP1286688A2 (en) 2003-03-05
CA2411432A1 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
ES2361993T5 (es) Tratamiento con enzimas de productos alimenticios para celiaquía
AP1398A (en) Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives.
IL207166A0 (en) Pharmaceutical compositions for treating amyloid diseases
WO2004066805A3 (en) In vivo device for improving diastolic ventricular function
GB0318447D0 (en) Therapeutic agents
GB0225474D0 (en) Therapeutic agents
GB0223038D0 (en) Therapeutic compounds
ATE232396T1 (de) Oxydiertes thymosin beta 4
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
RS8504A (en) Novel cyclohexil sulphones
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
WO2005012330A3 (en) AMYLOID β-PEPTIDE AND METHODS OF USE
MXPA02012089A (es) Metodo de tratamiento de la enfermedad de alzheimer con una proteina extraible de organos mamiferos.
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
TR200200278T2 (tr) Kalsilitik bileşimler
ITTO20000674A0 (it) Composizioni a base di aminoacidi, atte al trattamento dell'insufficienza cardiaca.
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
DE69621786T2 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
AUPP823999A0 (en) A treatment
MXPA02012091A (es) Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero.
MXPA02012092A (es) Metodo de tratamiento de la enfermedad de parkinson con una proteina extraible de organos.
MXPA02012090A (es) Un metodo de tratamiento de corea de huntington con una proteina que se puede extraer de organos de mamifero.
DE60124093D1 (de) S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
DE60123105D1 (de) Verfahren zur Herstellung von 4'-O-substituierten 4'-Demethyl-1 desoxypodophyllotoxinderivaten und geometrischen Isomeren davon ,und Antikrebspräparat, das diese enthält
SE9902674D0 (sv) New composition